Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TriSalus Life Sciences Inc (TLSI)

  • Business News
  • Dec. 04, 2025, 21:01 UTC
  • 14
  • 1 comments

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025

Market reaction Comment Full text

TriSalus Life Sciences Inc (TLSIW)

  • Business News
  • Dec. 04, 2025, 21:01 UTC
  • 10
  • 1 comments

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025

Market reaction Comment Full text

Capricor Therapeutics Inc. (CAPR)

  • Business News
  • Dec. 04, 2025, 21:01 UTC
  • 10
  • 1 comments

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

Market reaction Comment Full text

Neurogene Inc. (NGNE)

  • Business News
  • Dec. 04, 2025, 21:01 UTC
  • 11
  • 1 comments

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Praxis Precisions Medicines Inc (PRAX)

  • Business News
  • Dec. 04, 2025, 21:01 UTC
  • 12
  • 1 comments

Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 04, 2025, 20:40 UTC
  • 11
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

Codexis Inc (CDXS)

  • Business News
  • Dec. 04, 2025, 19:55 UTC
  • 10
  • 1 comments

Codexis Featured in CBS’s Economy 4.0 Docuseries Highlighting RNA Manufacturing Innovation

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • Dec. 04, 2025, 18:47 UTC
  • 6
  • 1 comments

New SEC Form for ResMed Inc.

Market reaction Comment Full text

Halozyme Therapeutics Inc (HALO)

  • Business News
  • Dec. 04, 2025, 18:27 UTC
  • 6
  • 1 comments

Halozyme - Halozyme Wins Preliminary Injunction Against Mercks Keytruda SC in Germany

Market reaction Comment Full text

Halozyme Therapeutics Inc (HALO)

  • Business News
  • Dec. 04, 2025, 18:26 UTC
  • 7
  • 1 comments

Halozyme Wins Preliminary Injunction Against Mercks Keytruda SC in Germany

Market reaction Comment Full text
  • Previous
  • 419
  • 420
  • 421
  • 422
  • 423
  • Next

Search

News categories

  • Technical Exchange News(10917)
  • Event(2340)
  • SEC News(190936)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125002)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin